BIOFLUX SYSTEM USED IN KEY STUDIES TO IDENTIFY CAUSES AND TREATMENTS OF BLOOD CLOTS RELATED TO COVID-19
Potential treatments identified that may offer improved outcomes in COVID-19 patients with...
Posts about
News
LARGE-SCALE LUNG CANCER CLINICAL STUDY DEMONSTRATES ACCURACY AND SENSITIVITY OF FLUXION'S ERASE-SEQ LIQUID BIOPSY
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital...
FLUXION LAUNCHES BIOFLUX ONE, THE AFFORDABLE SYSTEM FOR CELL ANALYSIS UNDER LIVE SHEAR FLOW
All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration...
FLUXION LAUNCHES THREE NEW SPOTLIGHT™ LIQUID BIOPSY NGS PANELS
New panels target EGFR Pathways, clinically relevant myeloid genes, and TP53Alameda, CA, December...
FLUXION BIOSCIENCES RECEIVES FOUNDATIONAL PATENT COVERING NGS LIQUID BIOPSY APPROACH
Patented ERASE-Seq approach delivers ultra-high sensitivity somatic mutation detection using...
FLUXION BIOSCIENCES RECEIVES NIH GRANT FOR DEVELOPMENT OF ADVANCED NON-INVASIVE PRENATAL TEST
Grant will support development of Spotlight™ NIPT, a novel single-cell NGS assay for non-invasive...
WEBINAR - 4 WAYS TO IMPLEMENT NGS LIQUID BIOPSIES- WITHOUT UMI
Our CTO, Dr. Cristian Ionescu-Zanetti, presented this webinar on Thursday, August 1. The webinar...
FLUXION BIOSCIENCES JOINS BLOODPAC CONSORTIUM TO ACCELERATE LIQUID BIOPSY DEVELOPMENT
Participation will help advance liquid biopsy adoption by collaborating among key industry...
GLYCOCALYX RESEARCH ACCELERATES WITH THE BIOFLUX SYSTEM
Glycocalyx research utilizing the BioFlux System
RECENT PUBLICATIONS VALIDATE FLUXION'S LIQUID BIOPSY TECHNOLOGIES
Publications demonstrate depth and breadth of Fluxion’s liquid biopsy technologies